The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Open accessAbstract
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} ) and hydrogen peroxide (H 2 O 2 ) production in both sickle cell disease (SCD) patients and knockout-transgenic SCD mice. There was a significant increase in the plasma XO activity of SCD patients that was similarly reflected in the SCD mouse model. Western blot and enzymatic analysis of liver tissue from SCD mice revealed decreased XO content. Hematoxylin and eosin staining of liver tissue of knockout-transgenic SCD mice indicated extensive hepatocellular injury that was accompanied by increased plasma content of the liver enzyme alanine aminotransferase. Immunocytochemical and enzymatic analysis of XO in thoracic aorta and liver tissue of SCD mice showed increased vessel wall and decreased liver XO, with XO concentrated on and in vascular luminal cells. Steady-state rates of vascular O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} production, as indicated by coelenterazine chemiluminescence, were significantly increased, and nitric oxide ( ⋅ NO)-dependent vasorelaxation of aortic ring segments was severely impaired in SCD mice, implying oxidative inactivation of ⋅ NO. Pretreatment of aortic vessels with the superoxide dismutase mimetic manganese 5,10,15,20-tetrakis( N -ethylpyridinium-2-yl)porphyrin markedly decreased O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} levels and significantly restored acetylcholine-dependent relaxation, whereas catalase had no effect. These data reveal that episodes of intrahepatic hypoxia-reoxygenation associated with SCD can induce the release of XO into the circulation from the liver. This circulating XO can then bind avidly to vessel luminal cells and impair vascular function by creating an oxidative milieu and catalytically consuming ⋅ NO via O \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}\end{document} -dependent mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding of plasma XO to ECs can lead to vascular dysfunction (45, 71, 562, 612, 1010).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Self-citationRed Cell Metabolism: A Manual of Biochemical Methods.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-985_1 · Cited by 2,327
Radí, R., Beckman, J. S., Bush, K. M., & Freeman, B. Α. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,201
Self-citationRubbo, H., Radí, R., Trujillo, M., Telleri, R., Kalyanaraman, B., Barnes, S., KIRK, M. C., & Freeman, B. Α. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47160-8 · Cited by 1,350
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
Superoxide and peroxynitrite inatherosclerosis.
White, C. R., Brock, T. A., Chang, L. Y., Crapo, J. D., BRISCOE, P. M., Ku, D. D., Bradley, W. A., Gianturco, S. H., Gore, J. Z., & Freeman, B. Α. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1044 · Cited by 684
Self-citationKissner, R., Nauser, T., Bugnon, P., Lye, P. G., & Koppenol, W. H. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970160x · Cited by 629
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
Spontaneous oxygen radical generation by sickle erythrocytes.
Hebbel, R. P., Eaton, J. W., Balasingam, M., & Steinberg, M. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110724 · Cited by 444
Research works printed but not linked: 8
- 10.1182/blood.V94.5.1555 · DOI
- C O Enwonwu Med Sci Res 17, 997–998 (1989).
- C R Morris, F A Kuypers, S Larkin, N Sweeters, J Simon, E P Vichinsky, L A Styles Br J Haematol 111, 498–500 (2000).
- S Giler, O Sperling, S Brosh, I Urca, A De Vries Isr J Med Sci 11, 1225 (1975).
- K Wolko, J Krawczynski Mater Med Pol 6, 95–98 (1974).
- D A Parks, D N Granger Am J Physiol 245, G285–G289 (1983).
- Y Yokoyama, J S Beckman, T K Beckman, J K Wheat, T G Cash, B A Freeman, D A Parks Am J Physiol 258, G564–G570 (1990).
- E A Kowaluk, P Seth, H L Fung J Pharmacol Exp Ther 262, 916–922 (1992).
Cited by
Sorted by citations
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationPulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,467
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationPacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
New metal complexes as potential therapeutics
Zhang, C. X., & Lippard, S. J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00081-4 · Cited by 947
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 867
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 769
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 667
Kato, G. J., McGowan, V., Machado, R. F., Little, J. A., Taylor, J., Morris, C. R., Nichols, J. S., Wang, X., Poljakovic, M., Morris, S. M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2373 · Cited by 661
Self-citationROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis
Zheng, D., Liu, J., Piao, H., Zhu, Z., Wei, R., & Liu, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039241 · Cited by 592
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Self-citationSuperoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
Batinic̈‐Haberle, I., Reboucas, J. S., & Spasojević, I. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2876 · Cited by 539
Self-citationVascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure
Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., Kohler, C., Harrison, D. G., Hornig, B., & Drexler, H. (2002) · Circulation · doi:10.1161/01.cir.0000041431.57222.af · Cited by 525
Nader, É., Skinner, S. C., Romana, M., Fort, R., Lemonne, N., Guillot, N., Gauthier, A., Antoine‐Jonville, S., Renoux, C., Hardy‐Dessources, M., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01329 · Cited by 511
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Self-citationThe Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
Hebbel, R. P., Osarogiagbon, R. U., & Kaul, D. K. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 464
Xanthine oxidoreductase: One enzyme for multiple physiological tasks
Bortolotti, M., Polito, L., Battelli, M. G., & Bolognesi, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101882 · Cited by 405
Hydrogen peroxide is the major oxidant product of xanthine oxidase
Kelley, E. E., Khoo, N. K. H., Hundley, N. J., Malik, U. Z., Freeman, B. Α., & Tarpey, M. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.012 · Cited by 399
Self-citationKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Kato, G. J., Hebbel, R. P., Steinberg, M. H., & Gladwin, M. T. (2009) · American Journal of Hematology · doi:10.1002/ajh.21475 · Cited by 349
Self-citationMorris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka‐Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 328
Interplay between oxidant species and energy metabolism
Quijano, C., Trujillo, M., Castro, L., & Trostchansky, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.11.010 · Cited by 309
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Inflammation in sickle cell disease
Conran, N., & Belcher, J. D. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189012 · Cited by 316
Walter, P. B., Fung, E. B., Killilea, D. W., Jiang, Q., Hudes, M. L., Madden, J., Porter, J. B., Evans, P., Vichinsky, E. P., & Harmatz, P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06277.x · Cited by 291
Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease
Gladwin, M. T., Schechter, A. N., Ognibene, F. P., Coles, W. A., Reiter, C. D., Schenke, W. H., Csákó, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2003) · Circulation · doi:10.1161/01.cir.0000044943.12533.a8 · Cited by 275
Self-citationPathogenic mechanisms of pulmonary arterial hypertension
Chan, S. Y., & Loscalzo, J. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.09.006 · Cited by 269
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Self-citationHatoum, O. A., Binion, D. G., Otterson, M. F., & Gutterman, D. D. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00699-1 · Cited by 260
Heme Degradation and Vascular Injury
Belcher, J. D., Beckman, J. D., Balla, G., Balla, J., & Vercellotti, G. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2822 · Cited by 257
Battelli, M. G., Bolognesi, A., & Polito, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.022 · Cited by 256
“intrahepatic hypoxia/reoxygenation, which can induce XOR release into the circulation from an injured liver [216].”
BackgroundGhouleh, I. A., Khoo, N. K. H., Knaus, U. G., Griendling, K. K., Touyz, R. M., Thannickal, V. J., Barchowsky, A., Nauseef, W. M., Kelley, E. E., Bauer, P. M., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.011 · Cited by 252
Self-citationNur, E., Biemond, B. J., Otten, H.-M. M. B., Brandjes, D. P. M., Schnog, J. B., & the CURAMA Study Group (2011) · American Journal of Hematology · doi:10.1002/ajh.22012 · Cited by 255
Sickle cell disease vasculopathy: A state of nitric oxide resistance
Wood, K. C., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.008 · Cited by 252
Self-citationCantu-Medellin, N., & Kelley, E. E. (2013) · Redox Biology · doi:10.1016/j.redox.2013.05.002 · Cited by 237
Vinchi, F., Franceschi, L. D., Ghigo, A., Townes, T. M., Cimino, J. J., Silengo, L., Hirsch, E., Altruda, F., & Tolosano, E. (2013) · Circulation · doi:10.1161/circulationaha.112.130179 · Cited by 233
Self-citationNitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
Gladwin, M. T. (2011) · JAMA · doi:10.1001/jama.2011.235 · Cited by 223
Self-citationGeorge, A., Pushkaran, S., Konstantinidis, D. G., Koochaki, S., Malik, P., Mohandas, N., Zheng, Y., Joiner, C. H., & Kalfa, T. A. (2013) · Blood · doi:10.1182/blood-2012-07-441188 · Cited by 218
Kato, G. J., Martyr, S. E., Blackwelder, W. C., Nichols, J. S., Coles, W. A., Hunter, L. A., Brennan, M., Hazen, S. L., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05701.x · Cited by 213
Self-citationN-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Self-citationThe Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
Nader, É., Romana, M., & Connes, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00454 · Cited by 207
Solovey, A. N., Kollander, R., Shet, A. S., Milbauer, L. C., Choong, S., Panoskaltsis‐Mortari, A., Blazar, B. R., Kelm, R. J., & Hebbel, R. P. (2004) · Blood · doi:10.1182/blood-2003-10-3719 · Cited by 191
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
Ataga, K. I., Moore, C. G., Hillery, C. A., Jones, S., Whinna, H. C., Strayhorn, D., Sohier, C., Hinderliter, A. L., Parise, L. V., & Orringer, E. P. (2007) · Haematologica · doi:10.3324/haematol.11763 · Cited by 192
Pulmonary Complications of Sickle Cell Disease
Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 188
Self-citationBelcher, J. D., Mahaseth, H., Welch, T. E., Vilback, A. E., Sonbol, K. M., Kalambur, V. S., Bowlin, P. R., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2004 · Cited by 180
Oxidative stress in β-thalassaemia and sickle cell disease
Voskou, S., Aslan, M., Fanis, P., Phylactides, M., & Kleanthous, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.018 · Cited by 175
Self-citationOxidative Stress in Healthy and Pathological Red Blood Cells
Orrico, F., Laurance, S., Lopez, A. C., Lefevre, S. D., Thomson, L., Möller, M. N., & Ostuni, M. A. (2023) · Biomolecules · doi:10.3390/biom13081262 · Cited by 198
Baldus, S. E., Eiserich, J. P., Brennan, M., Jackson, R. M., Alexander, C. B., & Freeman, B. Α. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00993-0 · Cited by 170
Self-citationMorris, C. R., Kuypers, F. A., Lavrisha, L., Ansari, M., Sweeters, N., Stewart, M., Gildengorin, G. L., Neumayr, L., & Vichinsky, E. P. (2013) · Haematologica · doi:10.3324/haematol.2013.086637 · Cited by 171
Reactions of Manganese Porphyrins with Peroxynitrite and Carbonate Radical Anion
Ferrer‐Sueta, G., Vitturi, D. A., Batinic̈‐Haberle, I., Fridovich, I., Goldstein, S., Czapski, G., & Radí, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213302200 · Cited by 168
Self-citationSICKLE CELL DISEASE: ROLE OF REACTIVE OXYGEN AND NITROGEN METABOLITES
Wood, K. C., & Granger, D. N. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04639.x · Cited by 164
Nitric Oxide-dependent Generation of Reactive Species in Sickle Cell Disease
Aslan, M., Ryan, T. M., Townes, T. M., Coward, L. U., KIRK, M. C., Barnes, S., Alexander, C. B., Rosenfeld, S. S., & Freeman, B. Α. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208916200 · Cited by 167
Self-citationUnderstanding Sickle cell disease: Causes, symptoms, and treatment options
Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023) · Medicine · doi:10.1097/md.0000000000035237 · Cited by 189
Sickle cell disease and nitric oxide: A paradigm shift?
Mack, A. K., & Kato, G. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.010 · Cited by 166
An absence of reactive oxygen species improves the resolution of lung influenza infection
Snelgrove, R. J., Edwards, L., Rae, A. J., & Hussell, T. (2006) · European Journal of Immunology · doi:10.1002/eji.200635977 · Cited by 159
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy
Reiter, C. D., & Gladwin, M. T. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200303000-00001 · Cited by 161
Self-citationWallace, K. L., & Linden, J. M. (2010) · Blood · doi:10.1182/blood-2010-06-290643 · Cited by 152
Newer Aspects of the Pathophysiology of Sickle Cell Disease Vaso-Occlusion
Conran, N., Franco‐Penteado, C. F., & Costa, F. F. (2009) · Hemoglobin · doi:10.1080/03630260802625709 · Cited by 155
Cárdenes, N., Corey, C. G., Geary, L., Jain, S., Zharikov, S. I., Barge, S., Novelli, E. M., & Shiva, S. (2014) · Blood · doi:10.1182/blood-2013-09-529420 · Cited by 150
Protective effect of arginine on oxidative stress in transgenic sickle mouse models
Dasgupta, T., Hebbel, R. P., & Kaul, D. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.025 · Cited by 150
Chen, J., Fu, X., Wang, Y., Ling, M., McMullen, B. A., Kulman, J. D., Chung, D. W., & López, J. A. (2009) · Blood · doi:10.1182/blood-2009-03-213967 · Cited by 152
Cantú‐Medellín, N., & Kelley, E. E. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.02.081 · Cited by 148
Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion
Baldus, S. E., Heitzer, T. A., Eiserich, J. P., Lau, D., Mollnau, H., Ortak, M., Petri, S., Goldmann, B. U., Duchstein, H., Berger, J., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.003 · Cited by 144
Self-citationSabaa, N., Franceschi, L. D., Bonnin, P., Castier, Y., Malpeli, G., Debbabi, H., Galaup, A., Maïer-Redelsperger, M., Vandermeersch, S., Scarpa, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33308 · Cited by 145
Ou, J., Ou, Z., Jones, D. W., Holzhauer, S., Hatoum, O. A., Ackerman, A. W., Weihrauch, D., Gutterman, D. D., Guice, K., Oldham, K. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070589.61860.a9 · Cited by 138
Gordeuk, V. R., Sachdev, V., Taylor, J. G., Gladwin, M. T., Kato, G. J., & Castro, O. L. (2007) · American Journal of Hematology · doi:10.1002/ajh.21016 · Cited by 139
Self-citationWood, K. C., Hebbel, R. P., & Granger, D. N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3218fje · Cited by 133
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics
Batinic̈‐Haberle, I., Rajić, Z., Tovmasyan, A. G., Reboucas, J. S., Ye, X., Leong, K. W., Dewhirst, M. W., Vujašković, Ž., Benov, L., & Spasojević, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.046 · Cited by 134
Self-citationVasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 135
Self-citationBatinic̈‐Haberle, I., Spasojević, I., Stevens, R. D., Hambright, P., Neta, P., Okado‐Matsumoto, A., & Fridovich, I. (2004) · Dalton Transactions · doi:10.1039/b400818a · Cited by 133
Self-citationThe impact of xanthine oxidase (XO) on hemolytic diseases
Schmidt, H. M., Kelley, E. E., & Straub, A. C. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101072 · Cited by 133
Nitric oxide production from hydroxyurea
King, S. B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.073 · Cited by 133
Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
Malik, U. Z., Hundley, N. J., Romero, G., Radi, R., Freeman, B. A., Tarpey, M. M., & Kelley, E. E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.004 · Cited by 126
Self-citationInsight into the complex pathophysiology of sickle cell anaemia and possible treatment
Piccin, A., Murphy, C., Eakins, E., Rondinelli, M. B., Daves, M., Vecchiato, C., Wolf, D. G. F., Mahon, C. M., & Smith, O. P. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13212 · Cited by 134
Machado, R. F., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05432.x · Cited by 123
Self-citationBatinic̈‐Haberle, I., Spasojević, I., Stevens, R. D., Hambright, P., & Fridovich, I. (2002) · Journal of the Chemical Society Dalton Transactions · doi:10.1039/b201057g · Cited by 126
Self-citationMachado, R. F., Mack, A. K., Martyr, S. E., Barnett, C. F., MacArthur, P. H., Sachdev, V., Ernst, I., Hunter, L. A., Coles, W. A., Nichols, J., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06417.x · Cited by 122
Self-citationKaul, D. K., Liu, X.-D., Choong, S., Belcher, J. D., Vercellotti, G. M., & Hebbel, R. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01150.2003 · Cited by 116
Sickle cell anemia and vascular dysfunction: The nitric oxide connection
Akinsheye, I., & Klings, E. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22195 · Cited by 120
Red blood cells induce hypoxic lung inflammation
Kiefmann, R., Rifkind, J. M., Nagababu, E., & Bhattacharya, J. (2008) · Blood · doi:10.1182/blood-2007-09-113902 · Cited by 116
Morris, C. R., Gladwin, M. T., & Kato, G. J. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241447 · Cited by 116
Self-citationda Silva, D. G. H., Belini-Junior, E., de Almeida, E. A., & Bonini-Domingos, C. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.181 · Cited by 118
Eberhardt, R. T., McMahon, L. C., Duffy, S. J., Steinberg, M. H., Perrine, S. P., Loscalzo, J., Coffman, J. D., & Vita, J. A. (2003) · American Journal of Hematology · doi:10.1002/ajh.10387 · Cited by 114
Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy
Vona, R., Sposi, N. M., Mattia, L., Gambardella, L., Straface, E., & Pietraforte, D. (2021) · Antioxidants · doi:10.3390/antiox10020296 · Cited by 122
Cardiopulmonary Complications of Sickle Cell Disease: Role of Nitric Oxide and Hemolytic Anemia
Gladwin, M. T., & Kato, G. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.51 · Cited by 114
Self-citationSpasojević, I., Chen, Y., Noel, T. J., Yu, Y., Cole, M. P., Zhang, L., Zhao, Y., Clair, D. K. S., & Batinic̈‐Haberle, I. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.019 · Cited by 110
Self-citationEffect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice
Kaul, D. K., Liu, X.-D., Chang, H.-Y., Nagel, R. L., & Fabry, M. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21633 · Cited by 109
Lahaye, D., Muthukumaran, K., Hung, C., Gryko, D., Reboucas, J. S., Spasojević, I., Batinic̈‐Haberle, I., & Lindsey, J. S. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.015 · Cited by 110
Self-citationPathophysiology and therapy for haemoglobinopathies; Part I: sickle cell disease
Madigan, C., & Malik, P. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010659 · Cited by 111
The Perfusion Paradox and Vascular Instability in Sickle Cell Disease
NATH, K. A., KATUSIC, Z. S., & GLADWIN, M. T. (2004) · Microcirculation · doi:10.1080/10739680490278592 · Cited by 102
Self-citationHydroxyurea and Arginine Therapy: Impact on Nitric Oxide Production in Sickle Cell Disease
Morris, C. R., Vichinsky, E. P., van Warmerdam, J., Machado, L., Kepka‐Lenhart, D., Morris, S. M., & Kuypers, F. A. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200308000-00008 · Cited by 102
Dietlin, T. A., Hofman, F. M., Lund, B. T., Gilmore, W., Stohlman, S. A., & van der Veen, R. C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006640 · Cited by 105
Baldus, S. E., Köster, R., Chumley, P. H., Heitzer, T. A., Rudolph, V., Ostad, M. A., Warnholtz, A., Staude, H.-J., Thuneke, F., Koss, K., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.06.004 · Cited by 100
Self-citationRedox-dependent impairment of vascular function in sickle cell disease
Aslan, M., & Freeman, B. Α. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.014 · Cited by 97
Self-citationXanthine oxidoreductase in respiratory and cardiovascular disorders
Boueiz, A. R., Damarla, M., & Hassoun, P. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2008 · Cited by 100
Kato, G. J., Wang, Z., Machado, R. F., Blackwelder, W. C., Taylor, J. G., & Hazen, S. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07658.x · Cited by 96
Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion
Curek, G. D., Çört, A., Yücel, G., Demır, N., Öztürk, S., Elpek, G. Ö., Savaş, B., & Aslan, M. (2009) · Toxicology · doi:10.1016/j.tox.2009.11.003 · Cited by 94
Self-citationHydroxyurea induces the eNOS-cGMP pathway in endothelial cells
Čokić, V. P. (2006) · Blood · doi:10.1182/blood-2005-11-4454 · Cited by 94
Metadata
- Authors
- Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., Batinic-Haberle, I., White, C. R., & Freeman, B. A.
- Affiliations
- National Institutes of Health (US)
- Departments of Anesthesiology, Biochemistry and Molecular Genetics, Pathology, Medicine, and Surgery, Center for Free Radical Biology, Imaging Facility and Comprehensive Sickle Cell Disease Center, University of Alabama, Birmingham, AL 35233; Critical Care Medicine Department of the Warren G. Magnuson Clinical Center, and Laboratory of Chemical Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and Department of...
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 98
- Issue
- 26
- Pages
- 15215-15220
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC65009
- OpenAlex
- W2014093734
- Cited by
- 391
- References
- 67
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 14 · 2019: 18 · 2018: 15 · 2017: 14 · 2016: 9 · 2015: 17 · 2014: 17 · 2013: 16 · 2012: 11
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60hl058418-05)
- National Heart, Lung, and Blood Institute (R01HL64937, R01HL064937, P6-HL-58418, R01HL058115, R01-HL-58115)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- sickle cell disease, xanthine oxidase, superoxide, nitric oxide, hydrogen peroxide, hepatocyte injury, aorta, superoxide dismutase mimetic, manganese porphyrin
- MeSH terms
- Alanine Transaminase, Anemia, Sickle Cell, Animals, Endothelium, Vascular, Erythrocytes, Humans, Muscle Relaxation, Nitric Oxide, Superoxides, Xanthine Oxidase, Mice, Knockout, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review